1. Home
  2. MTEM

MTEM

Molecular Templates Inc.

Logo Molecular Templates Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Founded: N/A Country:
United States
United States
Employees: N/A City: AUSTIN
Market Cap: 9.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 63.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 1.80 EPS Growth: -92.71
52 Week Low/High: $1.68 - $9.45 Next Earning Date: 05-13-2024
Revenue: $57,306,000 Revenue Growth: 190.10%
Revenue Growth (this year): -77.39% Revenue Growth (next year): -89.24%

Share on Social Networks: